ReviewExpert opinion on investigational drugs2017

PI3Kδ-selective and PI3Kα/δ-combinatorial inhibitors in clinical development for B-cell non-Hodgkin lymphoma.

Benjamin L Lampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.